(Q33328154)

25 July 2017

Fludarabine, cyclophosphamide, and dexamethasone (FluCyD) combination is effective in pretreated low-grade non-Hodgkin's lymphoma (English)

1 reference

25 July 2017

1 reference

M Lazzarino

1

1 reference

25 July 2017

E Orlandi

2

1 reference

25 July 2017

M Montillo

3

1 reference

25 July 2017

A Tedeschi

4

1 reference

25 July 2017

G Pagnucco

5

1 reference

25 July 2017

C Astori

6

1 reference

25 July 2017

A Corso

7

1 reference

25 July 2017

E Brusamolino

8

1 reference

25 July 2017

L Simoncini

9

1 reference

25 July 2017

E Morra

10

1 reference

25 July 2017

C Bernasconi

11

1 reference

25 July 2017

language of work or name

1 reference

1 January 1999

1 reference

25 July 2017

1 reference

25 July 2017

10

1 reference

25 July 2017

59-64

1 reference

25 July 2017

1

1 reference

Fludarabine phosphate for the treatment of low grade lymphoid malignancy

25 July 2017

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008376728894

7 January 2021

Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008376728894

7 January 2021

Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008376728894

7 January 2021

Fludarabine: an active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008376728894

7 January 2021

Fludarabine: a phase II trial in patients with previously treated low-grade lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008376728894

7 January 2021

Phase II trial of fludarabine monophosphate in patients with mantle-cell lymphomas.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008376728894

7 January 2021

Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008376728894

7 January 2021

Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008376728894

7 January 2021

Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008376728894

7 January 2021

Fludarabine-mitoxantrone combination-containing regimen in recurrent low-grade non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008376728894

7 January 2021

Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008376728894

7 January 2021

Phase I study of fludarabine and paclitaxel for the treatment of low-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008376728894

7 January 2021

Identifiers

DOI

10.1023/A:1008376728894

1 reference

25 July 2017

1 reference